Skip to main content
OpenTrials

Clinical trial condition

FGFR2 Gene Translocation

Explore clinical trials studying FGFR2 Gene Translocation. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

FGFR2 Gene Translocation trial results

Completed

REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

NCT04526106

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 48 locations
View Trial Details

Related conditions